CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Clinical trials for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) explained in plain language.
Never miss a new study
Get alerted when new CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) trials appear
Sign up with your email to follow new studies for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Brain games may keep psychosis at bay in At-Risk youth
Symptom relief Recruiting nowThis study tests whether fun computer-based brain exercises can help young people at high risk for psychosis think more clearly and function better at school, work, or with friends. Fifty-four participants in Tunisia will either do 12 weeks of cognitive training or receive standa…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC
-
Can online therapy prevent psychosis in At-Risk youth?
Knowledge-focused Recruiting nowThis study tests whether therapy delivered via telehealth can help teens and young adults (ages 14-25) who are at high risk for psychosis. Participants will receive group, family, or individual cognitive behavioral therapy (CBT) online. Researchers will measure how well these pro…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated May 26, 2026 03:21 UTC
-
Mindfulness under the microscope: new study probes risks and realities for Psychosis-Prone youth
Knowledge-focused Recruiting nowThis study interviews 20 people aged 15–30 who are at ultra-high risk for psychosis or have had a first episode. They all took part in a group mindfulness program. Researchers want to understand what the experience was like for them and whether any negative effects occurred. The …
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: Centre Psychothérapique de Nancy • Aim: Knowledge-focused
Last updated May 26, 2026 03:17 UTC
-
Could this drug help spot early signs of psychosis? new study investigates
Knowledge-focused Recruiting nowThis study looks at whether a new drug called MT1988 can cause changes in thinking, symptoms, and other measures in people aged 17 to 30 who are at high risk for psychosis. Participants take the drug or a placebo twice daily for 8 weeks and complete regular tests. The goal is not…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: PHASE1, PHASE2 • Sponsor: Monument Therapeutics Limited • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC
-
New french test could spot psychosis risk years early
Knowledge-focused Recruiting nowThis study aims to validate a French version of a questionnaire that helps detect very early signs of psychosis risk in teenagers aged 12 to 17. Researchers will check if different clinicians give consistent scores when using the tool. The goal is to improve early detection and s…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: Centre Psychothérapique de Nancy • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC